American Thoracic Society Recognizes Scleroderma Foundation Collaboration
Monday, June 3, 2013
By: Christina Relacion

Scleroderma Foundation recognized for its partnership with ATS on a two-year research grant

The American Thoracic Society (ATS) recently held their annual meeting in Philadelphia. The Scleroderma Foundation was recognized for its partnership with ATS on a two-year research grant. Kerri Connolly (pictured left), the Foundation’s Director of Programs and Services, accepted the recognition at an event held May 19.

Earlier this year, the organization announced a partnership for a two-year research grant specific to lung involvement in scleroderma.

ATS is one of the nation’s leading medical professional organizations that is comprised of thoracic and pulmonary experts from around the world. This research partnership helps the Scleroderma Foundation reach even further among researchers working on finding advancements in lung disease and scleroderma.

SF also Joins the ATS Public Advisory Roundtable

The ATS Public Advisory Roundtable (ATS PAR) is a core component of the American Thoracic Society and a mutually beneficial partnership wherein organizations that represent persons affected by respiratory diseases, sleep-related conditions, or related critical illnesses collaborate with the American Thoracic Society to advance their shared educational, research, patient care, and advocacy goals. The Scleroderma Foundation is delighted to participate on the ATS PAR group to provide the scleroderma patient’s perspective to the Society and to provide the Board of Directors with strategic guidance to keep patients and families as a central focus of all ATS activities and programs.